179 related articles for article (PubMed ID: 26119219)
21. Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway.
De Ridder M; Van Esch G; Engels B; Verovski V; Storme G
Bull Cancer; 2008 Mar; 95(3):282-91. PubMed ID: 18390408
[TBL] [Abstract][Full Text] [Related]
22. Pretreatment microRNA Expression Impacting on Epithelial-to-Mesenchymal Transition Predicts Intrinsic Radiosensitivity in Head and Neck Cancer Cell Lines and Patients.
de Jong MC; Ten Hoeve JJ; Grénman R; Wessels LF; Kerkhoven R; Te Riele H; van den Brekel MW; Verheij M; Begg AC
Clin Cancer Res; 2015 Dec; 21(24):5630-8. PubMed ID: 26265694
[TBL] [Abstract][Full Text] [Related]
23. Unravelling the biology of human papillomavirus (HPV) related tumours to enhance their radiosensitivity.
Vozenin MC; Lord HK; Hartl D; Deutsch E
Cancer Treat Rev; 2010 Dec; 36(8):629-36. PubMed ID: 20417037
[TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial.
Bentzen SM; Atasoy BM; Daley FM; Dische S; Richman PI; Saunders MI; Trott KR; Wilson GD
J Clin Oncol; 2005 Aug; 23(24):5560-7. PubMed ID: 16110017
[TBL] [Abstract][Full Text] [Related]
25. [Anemia in head and neck cancers].
Azria D; Zouhair A; Serre A; Lemanski C; Schneider M; Ozsahin M; Dubois JB; Lartigau E;
Bull Cancer; 2005 May; 92(5):445-51. PubMed ID: 15932808
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit.
Raju U; Molkentine DP; Valdecanas DR; Deorukhkar A; Mason KA; Buchholz TA; Meyn RE; Ang KK; Skinner H
Cancer Med; 2015 Jan; 4(1):65-74. PubMed ID: 25355701
[TBL] [Abstract][Full Text] [Related]
27. Hyperbaric oxygen in the radiation treatment of head and neck cancers.
Sealy R
Radiother Oncol; 1991; 20 Suppl 1():75-9. PubMed ID: 2020773
[TBL] [Abstract][Full Text] [Related]
28. Predictive modeling of hypoxic head and neck cancers during fractionated radiotherapy with gold nanoparticle radiosensitization.
Huynh M; Kempson I; Bezak E; Phillips W
Med Phys; 2021 Jun; 48(6):3120-3133. PubMed ID: 33818799
[TBL] [Abstract][Full Text] [Related]
29. Expanding the therapeutic repertoire of epidermal growth factor receptor blockade: radiosensitization.
Gee JM; Nicholson RI
Breast Cancer Res; 2003; 5(3):126-9. PubMed ID: 12793892
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of radiosensitivity in head and neck cancer cells by ZD1839 ('IRESSA'), a selective epidermal growth factor receptor tyrosine kinase inhibitor.
Shintani S; Kiyota A; Mihara M; Sumida T; Kayahara H; Nakashiro K; Hamakawa H
Am J Clin Oncol; 2003 Oct; 26(5):e150-6. PubMed ID: 14528090
[TBL] [Abstract][Full Text] [Related]
31. Rationale and clinical basis for combining gefitinib (IRESSA, ZD1839) with radiation therapy for solid tumors.
Ochs JS
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):941-9. PubMed ID: 14967454
[TBL] [Abstract][Full Text] [Related]
32. [Radio-chemotherapy in head and neck cancer (EGFR+)].
Ozsahin M; Matzinger O; Zimmermann M; Zouhair A
Bull Cancer; 2007 Sep; 94(9):828-32. PubMed ID: 17878104
[TBL] [Abstract][Full Text] [Related]
33. Potential indicators of radiosensitivity in squamous cell carcinoma of the head and neck.
Sheridan MT; O'Dwyer T; Seymour CB; Mothersill CE
Radiat Oncol Investig; 1997; 5(4):180-6. PubMed ID: 9327497
[TBL] [Abstract][Full Text] [Related]
34. Micro-RNAs, the Cornerstones of the Future of Radiobiology in Head and Neck Cancers?
Mireștean CC; Iancu RI; Iancu DPT
Curr Oncol; 2022 Feb; 29(2):816-833. PubMed ID: 35200568
[TBL] [Abstract][Full Text] [Related]
35. Interaction of EGFR with the tumour microenvironment: implications for radiation treatment.
Nijkamp MM; Span PN; Bussink J; Kaanders JH
Radiother Oncol; 2013 Jul; 108(1):17-23. PubMed ID: 23746695
[TBL] [Abstract][Full Text] [Related]
36. Anemia, tumor hypoxemia, and the cancer patient.
Varlotto J; Stevenson MA
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):25-36. PubMed ID: 16111569
[TBL] [Abstract][Full Text] [Related]
37. Oxygen-modifying treatment with ARCON reduces the prognostic significance of hemoglobin in squamous cell carcinoma of the head and neck.
Hoogsteen IJ; Pop LA; Marres HA; Merkx MA; van den Hoogen FJ; van der Kogel AJ; Kaanders JH
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):83-9. PubMed ID: 16213107
[TBL] [Abstract][Full Text] [Related]
38. Impact of anemia in patients with head and neck cancer treated with radiation therapy.
Hu K; Harrison LB
Curr Treat Options Oncol; 2005 Jan; 6(1):31-45. PubMed ID: 15610713
[TBL] [Abstract][Full Text] [Related]
39. A multidisciplinary approach to squamous cell carcinomas of the head and neck: an update.
Bernier J
Curr Opin Oncol; 2008 May; 20(3):249-55. PubMed ID: 18391622
[TBL] [Abstract][Full Text] [Related]
40. Chemoradiotherapy: emerging treatment improvement strategies.
Milas L; Mason KA; Liao Z; Ang KK
Head Neck; 2003 Feb; 25(2):152-67. PubMed ID: 12509799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]